What is Semble?
Semble Technology operates at the intersection of clinical efficiency and digital innovation. The company provides a comprehensive platform designed to streamline medical administration, enhance interoperability, and optimize patient engagement workflows. By leveraging data-driven insights, Semble empowers clinical teams to redefine care delivery models, effectively reducing the administrative burden that often hampers healthcare providers. Its market position is defined by a commitment to operational excellence, ensuring that medical practitioners can focus on patient outcomes rather than fragmented legacy systems. As the healthcare industry undergoes a rapid digital transformation, Semble serves as a critical infrastructure partner for clinics seeking to scale their operations while maintaining high standards of care.
How much funding has Semble raised?
Semble has raised a total of $58.5M across 3 funding rounds:
Seed
$3.2M
Series B
$15M
Series C
$40.3M
Seed (2019): $3.2M, investors not publicly disclosed
Series B (2024): $15M led by Triple Point and Octopus Ventures
Series C (2026): $40.3M supported by Partech, Mercia Asset Management, Revaia, and Octopus Ventures
Key Investors in Semble
Partech
Partech is a global investment firm with offices in San Francisco, Paris, Berlin and Dakar, bringing together capital, operational experience and strategic support for entrepreneurs at seed, venture and growth stages.
Mercia Asset Management
Mercia Asset Management provides equity and debt financing to UK businesses with growth ambitions, acting as investment partners from scale-up to exit.
Revaia
Revaia is a growth equity investment fund based in Paris that champions sustainable leaders in the field of technology and innovation.
What's next for Semble?
With the successful closure of this major strategic investment, Semble is well-positioned to accelerate its product roadmap and expand its footprint within the competitive health-tech market. The company is expected to prioritize the scaling of its interoperability features and the integration of advanced data analytics to further improve clinical decision-making. Given the current enterprise-level funding context, Semble will likely focus on strengthening its market share through strategic partnerships and potential geographic expansion. The continued support from seasoned venture capital firms suggests a clear path toward long-term sustainability and potential market leadership in the digital health ecosystem, as the firm continues to refine its value proposition for modern clinical environments.
See full Semble company page
